These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over

2024 has been a generally outstanding year for the stock market, with the S&P 500 (SNPINDEX: ^GSPC) up by nearly 30% year to date as of Dec. 11. However, not all stocks have performed nearly this well –- in fact, some components of the S&P 500 have underperformed the benchmark index by as much as 90 percentage points.

Here are the five worst-performing stocks in the S&P 500 in 2024, and what to keep in mind before you buy any of them.

Data source: yCharts. Performance as of 12/11/2024.

Should you buy these while they're cheap?

First, it's important to note that all of these are down for a reason. For example, Moderna is struggling with disappointing COVID-19 vaccine sales and an unclear path to future revenue growth. As another example, Walgreens' sales are rapidly losing ground to online competitors. But the point is that something has gone wrong in each of these businesses.

All of these could certainly end up being bargains at their current valuations, and in full disclosure, Moderna happens to be high on my watch list right now. Having said that, there's a lot that needs to go right before any of these stocks get back to where they were at the start of the year. Executing a turnaround strategy is never easy, so be sure you believe in a management team's plan before investing with these companies.

Should you invest $1,000 in Walgreens Boots Alliance right now?

Before you buy stock in Walgreens Boots Alliance, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Walgreens Boots Alliance wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $827,780!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

See the 10 stocks »

*Stock Advisor returns as of December 9, 2024

Matt Frankel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Intel. The Motley Fool recommends Moderna and recommends the following options: short February 2025 $27 calls on Intel. The Motley Fool has a disclosure policy.